Pharma and diagnostics to converge in personalised medicines

pharmafile | July 28, 2009 | News story | Research and Development, Sales and Marketing Diagnostics, strategy 

Related Content

Freenome raises $254m funding for early cancer detection platform

Freenome has announced that it has raised $254m from new and existing investors, intended to …

Tempus receives FDA Premarket Approval for in vitro diagnostic scan

US-based artificial intelligence (AI) and precision medicine company Tempus has announced that the US Food …

Roche building

Roche acquire GenMark in $1.8 billion deal

Pharmaceutical giant Roche have bought GenMark Diagnostics in a deal worth $1.8 billion, expanding their …

Latest content